SOPHiA GENETICS SA SOPH
Annual
Quarterly
FY2025 · ended Dec 31, 2025 · Revenue $77.27M, +18.6% YoY · Filed Mar 3, 2026
SOPHiA GENETICS SA (SOPH) files with the SEC under industry code 7374, Services-Computer Processing & Data Preparation. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $77.3 million and a net loss of $79.0 million. Free cash flow was -$36.5 million. As of Dec 31, 2025 it held $70.3 million in cash and investments and $63.0 million in total debt.
Revenue
$77.27M
+18.6% vs prior year
Net income
$-79.00M
-26.4% vs prior year
Operating cash flow
$-35.89M
+19.4% vs prior year
Free cash flow
$-36.47M
+18.5% vs prior year
EPS
$-1.17
-23.2% vs prior year
Dividend per share
None
Shares outstanding
68.49M
+2.7% vs prior year
Net cash
$7.27M
FY 2025
Operating margin
-91.8%
FY 2025
Company profile
- Industry
- Services-Computer Processing & Data Preparation (SIC 7374)
- Listed as
- SOPH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Rolle, Switzerland
- SEC filer status
- Accelerated filer, Emerging growth company
- SEC CIK
- 1840706
Other Services-Computer Processing & Data Preparation companies
- Automatic Data Processing Inc ADP
- Workday, Inc. WDAY
- Verisk Analytics, Inc. VRSK
- Toast, Inc. TOST
- Reddit, Inc. RDDT
- Hinge Health, Inc. HNGE
- RingCentral, Inc. RNG
- Pegasystems Inc PEGA
All 110 Services-Computer Processing & Data Preparation companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $77.3M | $65.2M | $62.4M | $47.6M | $40.5M |
| Operating income | -$70.9M | -$66.6M | -$74.8M | -$87.8M | — |
| Net income | -$79.0M | -$62.5M | -$79.0M | -$87.4M | -$73.7M |
| Diluted EPS | -$1.17 | -$0.95 | -$1.22 | -$1.36 | — |
| Operating cash flow | -$35.9M | -$44.5M | -$53.2M | -$70.1M | -$57.9M |
| Free cash flow | -$36.5M | -$44.8M | -$54.7M | -$74.2M | -$60.6M |
| Total assets | $163.0M | $155.3M | $206.2M | $243.8M | $320.2M |
| Total liabilities | $115.9M | $58.8M | $54.7M | $43.7M | $44.8M |
| Stockholders' equity | $47.1M | $96.5M | $151.4M | $200.1M | $275.4M |
| Cash and investments | $70.3M | $80.2M | $123.3M | $161.3M | $193.0M |
| Total debt | $63.0M | $30.0M | $18.6M | $16.7M | $13.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 4, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jun 22, 2026 | Jun 22, 2026 |
| 6-K | Current report (foreign issuer) | Jun 22, 2026 | Jun 18, 2026 |
| 6-K | Current report (foreign issuer) | Jun 4, 2026 | Jun 4, 2026 |
| 6-K | Current report (foreign issuer) | May 19, 2026 | May 19, 2026 |
All 501 SOPHiA GENETICS SA SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.